VALUATION DIAGNOSTIC
Pharma Manufacturing & CDMO
Specific market analysis for Pharma Manufacturing & CDMO companies based in Zug.
Pro-Forma Valuation
Market demand in Zug for Pharma Manufacturing & CDMO assets remains strong.
KEY DRIVER
"GMP moats, Basel supply chain, Lonza model, biologics shift, capacity scarcity."
Local Multiples (Est.)
6.0 - 8.0x Statutory
Get Your Report
Generate a certified valuation for your Pharma Manufacturing & CDMO business in Zug.
Valuation Impact by Size (DACH 2025)
| Size Bucket | Multiple Range | Impact |
|---|---|---|
| Micro (< CHF 1M EBITDA) | 3.5x - 4.8x | -33.3% |
| Small (CHF 1M - 2M EBITDA) | 4.9x - 6.6x | -6.7% |
| Transition (CHF 2M - 5M EBITDA) | 6.0x - 8.0x | +11.1% |
| Lower Mid-Market (CHF 5M - 10M EBITDA) | 8.1x - 11.0x | +33.3% |
| Mid-Market (> CHF 10M EBITDA) | 10.3x - 13.9x | +66.7% |
Source: NIMBO, Dealsuite, KPMG, SECA, Practitioner Interviews // Niche Baseline: 7x
Pharma Manufacturing & CDMO Market in Zug
Zug — known for its status as Crypto Valley, numerous global headquarters, a favorable tax environment — represents a significant market for Pharma Manufacturing & CDMO companies in Switzerland. The local business environment is shaped by the canton's economic profile, offering distinct opportunities for both buyers and sellers in this niche.
Current EBITDA multiples for Pharma Manufacturing & CDMO businesses range from 6.0 - 8.0x (statutory) to 8.0 - 12.0x (deal), reflecting a significant arbitrage opportunity. The sector trend is rising, driven by: GMP moats, Basel supply chain, Lonza model, biologics shift, capacity scarcity. This positions Zug as a notable market within the broader Life Sciences & Pharma sector.
Zug — Economy Snapshot
- Corporate Tax
- 11.9%
- #1/26
- Companies
- 20'500
- 98.8% SME
- Unemployment
- 1.7%
- Median Salary
- CHF 7'800
- /month
- Succession Risk
- 28%
- owners 55+
Why Pharma Manufacturing & CDMO in Zug?
Zug offers a diversified economic base with 20'500 total companies. While not a primary hub for Pharma Manufacturing & CDMO, the canton's competitive tax environment and skilled workforce create favorable conditions for business operations and valuations.
- Switzerland's lowest corporate tax rate at 11.9% with minimal personal income taxation, creating an unmatched fiscal advantage
- World-renowned 'Crypto Valley' ecosystem making Zug Europe's leading hub for blockchain, digital assets, and fintech innovation
- Extraordinary concentration of multinational headquarters and commodity-trading firms driving high-value economic activity
Tax Impact on Valuation
At Zug's effective corporate tax rate of 11.9% (rank #1/26), after-tax EBITDA retention is 88.1%. This directly influences enterprise valuations and buyer economics in the Pharma Manufacturing & CDMO sector.
FAQ: Pharma Manufacturing & CDMO in Zug
How many Pharma Manufacturing & CDMO companies are in Zug?
Zug has 20'500 total companies. Specific Pharma Manufacturing & CDMO company counts are part of the broader industrial landscape.
What is the corporate tax rate in Zug?
The effective corporate tax rate in Zug is 11.9%, ranking #1 among Switzerland's 26 cantons.
What are Pharma Manufacturing & CDMO valuation multiples in Zug?
Current statutory EBITDA multiples for Pharma Manufacturing & CDMO range from 6.0 - 8.0x. Deal-based multiples are 8.0 - 12.0x. These are influenced by Zug's tax environment and local market conditions.
What is the business succession outlook in Zug?
While Zug's succession challenge is proportionally less acute than in more rural cantons -- with 28% of owners over 55 versus 35-38% in Glarus or Obwalden -- the absolute numbers are significant given the canton's large company base. Many of Zug's succession-relevant companies are in traditional SME sectors such as construction, retail, and professional services, coexisting alongside the highly dynamic startup and multinational ecosystem. The deep advisory infrastructure and active M&A market in Zug mean that succession solutions are more readily available than in smaller cantons.
Canton hub: tax data, industry composition, key employers
Full Swiss market analysis across all 26 cantons, including comparable M&A transactions and sector trends.
Pharma Manufacturing & CDMO Valuations Across Switzerland
Compare Pharma Manufacturing & CDMO business valuation benchmarks in other Swiss cantons and cities.
Other Industries in Zug
Explore valuation data for different sectors based in Zug.